独家

埃森哲将为所有20万名员工及其家属支付Covid疫苗接种费用

埃森哲印度董事长Rekha M. Menon表示:“对于符合条件并选择接受Covid-19疫苗接种的员工,埃森哲将为员工及其家属支付费用,这些家属是我们医疗福利计划的一部分。”

据其中一些公司的高管说,有几家公司已准备好为员工承担疫苗接种费用。工业界也在寻求企业社会责任支出所涵盖的成本。
据其中一些公司的高管说,有几家公司已准备好为员工承担疫苗接种费用。工业界也在寻求企业社会责任支出所涵盖的成本。
全球领先的IT和专业服务公司埃森哲咨询公司将为其在印度的20万名员工及其参加公司医疗福利计划的家属支付Covid - 19疫苗接种费用。

埃森哲印度董事长兼高级董事总经理Rekha M. Menon表示:“对于符合条件并选择接受Covid-19疫苗接种的员工,埃森哲将为员工及其家属支付费用,这些家属是我们医疗福利计划的一部分。”

“在我们继续应对大流行之际,没有什么比人民的健康和福祉更重要。在埃森哲印度分公司,我们继续监测和考虑外部专家和团体的指导,包括国际卫生组织和地方卫生当局。基于此,我们强烈支持鼓励接种疫苗的科学和公共卫生建议。”

《经济时报》曾在1月份报道称,几家顶级企业集团和企业,再见马辛德拉Marico,马鲁蒂铃木电视电动机,吠檀多我们正加紧从制造商和供应商处获得疫苗,为其员工提供下一阶段的疫苗接种。

3月1日,政府的Covid-19疫苗接种推广程序扩大到包括60岁以上和45至59岁有特定共病的符合条件的公民。

据其中一些公司的高管说,有几家公司已准备好为员工承担疫苗接种费用。工业界也在寻求企业社会责任支出所涵盖的成本。

关注并与我们联系脸谱网LinkedinYoutube
\"
Several companies are ready to absorb the vaccination costs for their employees, according to executives at some of these companies. Industry is also seeking the cost to be covered under the corporate social responsibility spending.<\/span><\/figcaption><\/figure>Leading global IT and professional services company Accenture<\/a> will cover the cost of Covid 19 vaccination for all its 200,000 employees in India as well as their dependents who are enrolled on the company\u2019s medical benefits programme.

\u201cFor employees who are eligible and choose to receive the Covid-19 vaccination, Accenture will cover the cost for the employee and their dependents who are part of our medical benefits program,\u201d said Rekha M. Menon, Chairperson and senior managing director, Accenture in India.

\u201cAs we continue to navigate the pandemic, nothing is more important than the health and well-being of our people. At Accenture in India we have continued to monitor and consider the guidance of external experts and groups, including international health organisations and local health authorities. Based on this, we strongly support the scientific and public health advice that encourages vaccination,\u201d said Menon.